Abstract:Acetes chinensis is an underutilized shrimp species thriving in the Bo Hai Gulf of China. In a previous study, we had used the protease from Bacillus sp. SM98011 to digest this kind of shrimp and found that the oligopeptide‐enriched hydrolysate possessed antioxidant activity and high angiotensin I‐converting enzyme (ACE) inhibitory activity with an IC50 value of 0.97 mg/ml. In this paper, by ultrafiltration, gel permeation chromatography and reversed‐phase high‐performance liquid chromatography (RP‐HPLC), five peptides with high ACE inhibitory activity were purified from the shrimp hydrolysates and their sequences were identified by amino acid composition analysis and molecular weight (MW) analysis. Three of them, FCVLRP (a), IFVPAF (f) and KPPETV (j), were novel ACE inhibitory peptides. Their IC50 values were 12.3 µM, 3.4 µM and 24.1 µM, respectively, and their recoveries were 30 mg/100 g (solid basis of shrimp), 19 mg/100 g and 33 mg/100 g, respectively. Lineweaver‐Burk plots for the three novel peptides showed that they are all competitive inhibitors. To test the ACE inhibitory activity of peptide a, f, j after they were digested by digestive enzymes in vivo, 12 derived peptides from FCVLRP and IFVPAF were synthesized based on their amino acid sequences and the cleavage sites of digestive enzymes. No digestive enzyme cleavage site was found in KPPETV. The IC50 values of the derived peptides were determined and the result showed that except for VPAF, FC and FCVL, the ACE inhibitory activity of the other nine derived peptides did not significantly change when compared with their original peptides. Surprisingly, five peptides had lower IC50 values than their original peptides, particularly for RP (IC50 value = 0.39 µM), which is about 30 times lower than its original peptide and almost the lowest IC50 value for ACE inhibitory peptides reported. Therefore, the novel peptides identified from A. chinensis hydrolysates probably still maintain a high ACE inhibitory activity even if they are digested in vivo. This is the first report about novel ACE inhibitory peptides from hydrolysates of marine shrimp A. chinensis. The novel peptides from hydrolysate of A. chinensis and some of their derived peptides with high ACE inhibitory activity probably have potential in the treatment of hypertension or in clinical nutrition. Copyright © 2006 European Peptide Society and John Wiley & Sons, Ltd.

Novel Angiotensin-Converting Enzyme Inhibitory Peptides Derived from Tuna (thunnus Maccoyii): the Integration of Computer Tools with in Vitro Experiments

Angiotensin Converting Enzyme (ACE) Inhibitory Peptide from the Tuna (thunnus Thynnus) Muscle: Screening, Interaction Mechanism and Stability

Preparation, Characterization, and Cytoprotective Effects on HUVECs of Fourteen Novel Angiotensin-I-Converting Enzyme Inhibitory Peptides From Protein Hydrolysate of Tuna Processing By-Products

Identification and in Silico Screening of Novel Angiotensin-Converting Enzyme Inhibitory Peptides from Pacific Saury: Interaction Mechanism, Network Pharmacology, Stability, Caco-2 Monolayer Transport

Discovery of Novel Angiotensin-Converting Enzyme Inhibitory Peptides from Todarodes Pacificus and Their Inhibitory Mechanism: in Silico and in Vitro Studies

The novel angiotensin-I-converting enzyme inhibitory peptides from Scomber japonicus muscle protein hydrolysates: QSAR-based screening, molecular docking, kinetic and stability studies

Biodirected Screening and Preparation of Larimichthys crocea Angiotensin-I-Converting Enzyme-Inhibitory Peptides by a Combined In Vitro and In Silico Approach

Novel angiotensin-converting enzyme inhibitory peptides from tuna byproducts—milts: Preparation, characterization, molecular docking study, and antioxidant function on H2O2-damaged human umbilical vein endothelial cells

A novel angiotensin-converting enzyme (ACE) inhibitory peptide from tilapia skin: Preparation, identification and its potential antihypertensive mechanism

Novel Natural Angiotensin Converting Enzyme (ACE)-Inhibitory Peptides Derived from Sea Cucumber-Modified Hydrolysates by Adding Exogenous Proline and a Study of Their Structure–Activity Relationship

Identification and Molecular Docking Study of Novel Angiotensin-Converting Enzyme Inhibitory Peptides from Salmo Salar Using in Silico Methods.

Identification and Molecular Mechanism of Angiotensin-Converting Enzyme Inhibitory Peptides from Larimichthys Crocea Titin

Novel Angiotensin-Converting Enzyme Inhibitory Peptides Derived from Oncorhynchus mykiss Nebulin: Virtual Screening and In Silico Molecular Docking Study.

Analysis of Novel Angiotensin‐i‐converting Enzyme Inhibitory Peptides from Protease‐hydrolyzed Marine Shrimp Acetes Chinensis

Integrated network pharmacology and experimental validation to explore the mechanisms of Coregonus peled -derived myosin ACE-inhibiting peptides for the treatment of hypertension

Production, identification, in silico analysis, and cytoprotection on H2O2-induced HUVECs of novel angiotensin-I-converting enzyme inhibitory peptides from Skipjack tuna roes

Identification of novel angiotensin converting enzyme (ACE) inhibitory peptides from Pacific saury: In vivo antihypertensive effect and transport route

Integrating Computational Modeling and Experimental Assay to Discover New Potent Ace-Inhibitory Peptides

Purification and identification of novel angiotensin-I-converting enzyme inhibitory peptides from shark meat hydrolysate

Identification, structure-activity relationship and in silico molecular docking analyses of five novel angiotensin I-converting enzyme (ACE)-inhibitory peptides from stone fish (Actinopyga lecanora) hydrolysates

Isolation, Identification, and Molecular Docking Analysis of Novel ACE Inhibitory Peptides from Spirulina Platensis